The Social Responsiveness Scaleâ2 (SRSâ2) is a quantitative measure used to characterize symptoms of autism spectrum disorder (ASD). However, research suggests that SRSâ2 scores are significantly influenced by language ability and intellectual disability (ID). Efforts to refine the SRSâ2 by Sturm, Kuhfeld, Kasari, and Mccracken [Journal of Child Psychology and Psychiatry, 58(9), 1053â1061] yielded a shortened form, yet its psychometric properties in populations with severe ID remain unknown. This study aims to examine the psychometric properties of the SRSâ2 in PhelanâMcDermid syndrome (PMS), a genetic condition associated with ASD and ID, thereby guiding score interpretation in this population and future development of targeted scales. Analyses, including Item Response Theory (IRT), were conducted on a sample of individuals with PMS (n =â91) recruited at six sites nationally. Psychometric properties evaluated include measures of reliability (internal consistency, testâretest reliability) and validity (structural, construct, content). While both SRSâ2 forms are reliable, the shortened SRSâ2 shows superior validity to the full SRSâ2 for measuring ASD symptoms in PMS. On IRT analysis, the shortened SRSâ2 shows excellent discrimination and precisely evaluates respondents across a wide range of ASD symptomatology but interpretation is limited by uncertain content validity and small sample size. The shortened SRSâ2 shows some promise for use in PMS, but future refinements and additions are needed to develop items that are tailored to identify ASD in children with severe ID and specifically PMS.
Lay Summary
This study determined that a shortened form of the Social Responsiveness Scale, Second Edition (SRSâ2) shows both promise and limitations for the characterization of autism symptomatology in individuals with PhelanâMcDermid syndrome (PMS), a population characterized by intellectual disability (ID). Caution should be used when interpreting SRSâ2 scores in individuals with ID and future research should modify existing items and develop new items to improve the SRSâ2's ability to accurately characterize autism symptomatology in PMS. Autism Res 2020, 13: 1383â1396. © 2020 International Society for Autism Research, Wiley Periodicals, Inc.